Francois Grammont's Contact Details

Francois Grammont's Company Details

Aquyre Biosciences, Inc.

Cambridge, Massachusetts, United States • 13 Employees
Medical Devices

What Makes Aquyre Biosciences Different?Our technology combines two different proprietary technologies in one exam, offering non-invasive, non-destructive, intraprocedural tissue adequacy assessment, in freshly excised tissue, within 2 minutes.Our Technologies:- Full-Field Optical Coherence Tomography (FFOCT) offers en face (transverse), high resolution, 3D imaging of the tissue micro-architecture, at a resolution of 1μm. FFOCT also allows for depth exploration at different focal planes, without compromising 1μm resolution.- Dynamic Cell Imaging (DCI) - enhances the cellular contrast by capturing the residual microscopic intracellular activity and behaviors in freshly excised tissue, without staining or partially destroying the tissue. Patient Benefits:- quicker time to results; avoid potential delays waiting for results associated with sending the sample to the lab and waiting days for a report- avoid potential redo procedures- avoid potential delays in available treatment optionsClinician Benefits:- increase the tissue adequacy assessment rate with immediate access to tissue microarchitecture and cellular data at your fingertips - receiving immediate feedback and information may result in fewer passes and consequently few complications - creates more consistent workflow efficiencies throughout the day - improves productivity Hospital benefits:- impacts the quality of care by meeting an unmet need in the patient continuum of care- directly affects patient satisfaction scores- a direct impact on costs (ie- unnecessary redo procedures, wasted procedure suite/operating room time, etc.)- a positive effect on patient throughput where there are already constraints by labor shortages and physical resourcesToday's Mission: become the standard of care for tissue adequacy assessment